Towards a better understanding of the epidemiology of HIV-2.
about
Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West AfricaRisk to human health from a plethora of simian immunodeficiency viruses in primate bushmeatSeroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected GambiansUse of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteinsNatural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals.Noninvasive detection of new simian immunodeficiency virus lineages in captive sooty mangabeys: ability to amplify virion RNA from fecal samples correlates with viral load in plasma.Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource SettingsMutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.Recombinant viruses initiated the early HIV-1 epidemic in Burkina Faso.Human immunodeficiency virus type 2 in two Saudi families.Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West AfricaMale Circumcision and the Epidemic Emergence of HIV-2 in West Africa.Predicting the extinction of HIV-2 in rural Guinea-Bissau.Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitroPhenotypic susceptibility of HIV-2 to raltegravir: integrase mutations Q148R and N155H confer raltegravir resistance.HIV-2 diagnosis and quantification in high-risk patients.Trends of HIV-1 and HIV-2 prevalence among pregnant women in Guinea-Bissau, West Africa: possible effect of the civil war 1998 1999.Human Immunodeficiency Virus (HIV).Phylogenetic Analysis of Human Immunodeficiency Virus Type 2 Group B.Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.Antiretroviral drug resistance in human immunodeficiency virus type 2.Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-Bissau.Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.Antiretroviral drug resistance in HIV-2: three amino acid changes are sufficient for classwide nucleoside analogue resistance.An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa.
P2860
Q34046201-0F6475C3-0972-4BCF-8DEF-B4ABEEB5B3B0Q34127279-3A132DD3-8FEC-4747-BDD1-45D74861FADBQ34174489-1C918341-874C-4D57-A94E-C85D836445EAQ34430673-A6C31B29-8165-4BAD-8E91-8C071DA6A8EBQ34434825-9B6EF4F9-297F-4453-B7C0-60AB7CB7082FQ34437201-A820A4E9-03DC-48F2-80E9-97FA19CB0C7CQ34467648-03B9C42B-FFEE-4EFC-AD9D-057E2E3F4C28Q34730950-D74BA71C-96BE-4E8D-8217-B767DBA67073Q34992731-02F9DF3C-ED6A-420C-8325-0784EA7A71D3Q35125087-448D2542-E45F-496C-B46C-112916D1BF2EQ35165841-C2DC543B-9D91-4D15-A699-C050DD380B90Q35884346-3193BD4F-F275-4A5F-B665-6CCBC749190CQ36214981-2C9E4D5D-CA96-40F3-A899-129FB3AAFD0FQ36282706-FB343610-FAEF-4781-91BB-2DE8470D54E0Q36422635-0BE89338-B869-4903-AC18-21EDA3A3A749Q36839676-875B402C-8A84-420D-A0EF-891A8D159AEBQ36862541-84B232ED-7E33-4052-9AA1-F02689E38C36Q37006418-3957D5A5-539B-4614-867B-2E56C8934379Q37045832-7D433EE0-7C2C-4D47-BF4A-095E7A5FBFACQ37203656-1A4F3DCE-2419-4724-B241-71D14A3E85BFQ37256366-7B0B697D-4534-4546-8B08-E9938B0EBA0EQ37496287-2C2885E8-D504-4C4E-BA47-7A987793E0D1Q39437445-2FE1B539-DF14-42B8-B8DA-59762D06FE39Q41761525-B3BD5BCF-FB96-49D1-8755-C61884269964Q43070074-CB07E296-B2F4-4D5F-A74F-845064A44A0FQ46498843-8385BA59-5FAE-4EA6-AF73-546A63DFD24F
P2860
Towards a better understanding of the epidemiology of HIV-2.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Towards a better understanding of the epidemiology of HIV-2.
@ast
Towards a better understanding of the epidemiology of HIV-2.
@en
type
label
Towards a better understanding of the epidemiology of HIV-2.
@ast
Towards a better understanding of the epidemiology of HIV-2.
@en
prefLabel
Towards a better understanding of the epidemiology of HIV-2.
@ast
Towards a better understanding of the epidemiology of HIV-2.
@en
P1433
P1476
Towards a better understanding of the epidemiology of HIV-2
@en
P2093
Schim van der Loeff MF
P304
P407
P478
13 Suppl A
P577
1999-01-01T00:00:00Z